Ajanta Soya (519216)
CyclicalScore breakdown: P/E: 2/3 · ROCE: 2/2 · Growth: 0/2 · Dividend: 0/1
Key Financials
| Current Price | ₹30.76 |
| Market Cap | ₹247.57 Cr |
| P/E Ratio | 12.82 |
| ROCE | 26.76% |
| ROE | 10.2% |
| Dividend Yield | 0% |
| Profit Growth | -74.36% |
| Debt/Equity | — |
| Sales Growth | -14.71% |
| 52-Week Range | ₹16 — ₹39.87 |
| Sector | Agricultural Food & other Products |
| Book Value | ₹18.16 |
Strengths
- Trailing P/E of 12.82 with positive earnings
- ROCE of 26.76% suggests decent capital efficiency
- Book value of ₹18.16 provides some asset support
- Latest quarter still generated a net profit of ₹3 crore
Concerns
- Sales growth down 14.71% and profit growth down 74.36%
- Piotroski F-Score of 3/9 indicates weak fundamental health
- Latest quarter net margin is below 1% in a commoditized edible-oil business
- No dividend and no debt/equity data available to judge balance-sheet safety
AI Analysis
I approach Ajanta Soya with Graham's warning in mind: the figures must satisfy both quality and price. This is an edible-oil business—a commoditized industry where pricing power is scarce and margins are thin. The latest quarter tells the story: ₹312 crore of sales produced just ₹3 crore of net profit, a less than 1% net margin. In such a business, any input-price shock can wipe out returns. Sales are down 14.71% and profits are down 74.36%; this is not a company compounding wealth. Return on equity is a mediocre 10.20%, although ROCE reads 26.76%—an odd combination that makes me want to inspect capital structure carefully, especially since debt/equity data is not available. Piotroski F-Score of 3/9 is a red flag; it suggests deteriorating profitability, leverage, or efficiency. At ₹30.76, the stock trades at 12.82 times earnings and 1.69 times book value. Book value is ₹18.16, so you are paying a 69% premium for a shrinking business. No dividend compensates you while you wait. The 52-week range of ₹16 to ₹39.87 shows this is a volatile, cyclical commodity stock, not a predictable franchise. Graham would demand a margin of safety; I don't find it here. The only way this becomes interesting is if the edible-oil cycle turns, costs ease, and quarterly margins rebuild consistently. Until then, it is a low-quality commodity play dressed up with a low P/E. I'd rather wait for better evidence or a cheaper price. The burden of proof rests with the company, not with my portfolio.
Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer